Tumour necrosis factor alpha augments the release of an endothelium-dependent vasoconstrictor from human polymorphonuclear leukocytes.
Sobey, C G
Tumour necrosis factor alpha augments the release of an endothelium-dependent vasoconstrictor from human polymorphonuclear leukocytes. [electronic resource] - Journal of cardiovascular pharmacology 1992 - 813-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0160-2446
Acetylcholine--pharmacology
Animals
Aorta
Arginine--analogs & derivatives
Endothelium, Vascular--physiology
Humans
Molecular Weight
Neutrophils--drug effects
Nitric Oxide--metabolism
Nitroarginine
Peroxidase--metabolism
Rabbits
Recombinant Proteins--pharmacology
Tumor Necrosis Factor-alpha--pharmacology
Vasoconstriction
Vasoconstrictor Agents--metabolism
Tumour necrosis factor alpha augments the release of an endothelium-dependent vasoconstrictor from human polymorphonuclear leukocytes. [electronic resource] - Journal of cardiovascular pharmacology 1992 - 813-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0160-2446
Acetylcholine--pharmacology
Animals
Aorta
Arginine--analogs & derivatives
Endothelium, Vascular--physiology
Humans
Molecular Weight
Neutrophils--drug effects
Nitric Oxide--metabolism
Nitroarginine
Peroxidase--metabolism
Rabbits
Recombinant Proteins--pharmacology
Tumor Necrosis Factor-alpha--pharmacology
Vasoconstriction
Vasoconstrictor Agents--metabolism